Full Length Research Paper
References
| Ahmed ZB, Ayad A, Mesli E, Messai Y, Bakour R, Drissi M (2012). CTX-M-15 extended-spectrum beta-lactamases in Enterobacteriaceae in the intensive care unit of Tlemcen Hospital, Algeria. East. Mediterr. Health 18(4): 382-386. | ||||
|
Al-Agamy MH, Shibl AM, Tawfik AF (2009). Prevalence and molecular characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Ann. Saudi Med. 29(4): 253-257. Crossref |
||||
|
Ben Haj Khalifa A, Khedher M (2009). Epidemiological study of Klebsiella spp. uropathogenic strains producing extended-spectrum beta-lactamase in a Tunisian university hospital, 2009. Pathol. Biol. 60(2): e1–e5. Crossref |
||||
|
Bonnet R (2004). Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48: 1-14. Crossref |
||||
|
Bonnet R, Sampaio JL, Chanal C, Sirot D, De Champs C, Viallard JL et al (2000). A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens isolated in Brazil. Antimicrob. Agents Chemother. 4(11): 3061-3068. Crossref |
||||
|
Bush K, Jacoby GA, Meideros AA (1995). A functional classification scheme for b-lactamase and its correlation with molecular structures. Antimicrob. Agents Chemother. 39: 1211-1233. Crossref |
||||
| Carrer A, Nordmann P (2011). CTX-M-15 producing Klebsiella pneumoniae: a change in the epidemiology of ESBL. Biol. Pathol. 59: E133-135. | ||||
| CASFM (2010). Antibiogram Committee of French Society for Microbiology. Communique 2010. Paris. France. View | ||||
|
De Champs C, Chanal C, Sirot D Baraduc R, Romaszko JP, Bonnet R, Plaidy A, Boyer M, Carroy E, Gbadamassi MC et al. (2004). Frequency and diversity of class A extended-spectrum beta-lactamases in hospitals of the Auvergne, France: a 2 year prospective study. J. Antimicrob. Chemother. 54: 634–639. Crossref |
||||
|
Dumarche P, De Champs C, Sirot D, Chanal C, Bonnet R, Sirot J (2002). TEM derivative-producing Enterobacter aerogenes strains: dissemination of a prevalent clone. Antimicrob. Agents Chemother. 46: 1128-1131. Crossref |
||||
|
Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L (2003). Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob. Agents Chemother. 47: 3724-3732. Crossref |
||||
| Elhani D, Bakir L, Aouni M (2011). The changing epidemiology of extended spectrum β-lactamase-producing Klebsiella pneumoniae. Ann. Biol. Clin. 69(5): 523-529. | ||||
|
Guo Q, Wang P, Ma Y, Yang Y, Ye X, Wang M (2012). Co-production of SFO-1 and DHA-1 β-lactamases and 16S rRNA methylase ArmA in clinical isolates of Klebsiella pneumoniae. J. Antimicrob. Chemother. 67(10): 2361-2366. Crossref |
||||
|
Hanson ND (2003). AmpC beta-lactamases: what do we need to know for the future?. J. Antimicrob. Chemother. 52: 2-4. Crossref |
||||
|
Hennequin C, Robin F, Cabrolier N, Bonnet R, Forestier C (2012). Characterization of a DHA-1-producing Klebsiella pneumoniae strain involved in an outbreak and role of the AmpR regulator in virulence. Antimicrob. Agents Chemother. 56(1): 288-294. Crossref |
||||
|
Iabadene H, Messai Y, Ammari H, Alouache S, Verdet C, Bakour R, Arlet G (2009). Prevalence of plasmid-mediated AmpC β-lactamases among Enterobacteriaceae in Algiers hospitals. Int. J. Antimicrob. Agents 34(4): 340-342. Crossref |
||||
|
Jarlier V, Nicolas MH, Fournier G, Philippon A (1988). Extended-broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10: 867–878. Crossref |
||||
|
Lavigne JP, Marchandin H, Delmas J, Moreau J, Bouziges N, Lecaillon E et al. (2007). CTXM beta-lactamase-producting Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors. J. Clin. Microbiol. 45: 620–626. Crossref |
||||
|
Lebessi E, Dellagrammaticas H, Tassios PT et al. (2002). Extended spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensif care unit in the high prevalence area of Athens Greece. J. Clin. Microbiol. 40: 799-804. Crossref |
||||
|
Liu W, Chen L, Li H, Duan H, Zhang Y, Liang X et al. (2009). Novel CTX-M {beta}-lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China. J. Antimicrob. Chemother. 63: 895-900. Crossref |
||||
|
Mendonça N, Ferreira E, Louro D, Caniça M, ARSIP Participants (2009). Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum β-lactamase-producing Klebsiella pneumoniae isolated in Portugal. Int. J. Antimicrob. Agents 34: 29–37. Crossref |
||||
|
Mesko MK, Koren S, Palepou MF, Karisik E, Livermore DM, Pike R et al. (2009). Nationwide survey of CTX-M-type extended-spectrum b-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals. Antimicrob. Agents Chemother. 53: 287–791. Crossref |
||||
|
Messai Y, Iabadene H, Benhassine T, Alouache S, Tazir M, Gautier V, Arlet G, Bakour R (2008). Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria). Pathol. Biol. 56(5): 319-325. Crossref |
||||
|
Nedjai S, Barguigua A, Djahmi N, Jamali L, Zerouali K, Dekhil M, Timinouni M (2012). Prevalence and characterization of extended spectrum β-lactamases in Klebsiella-Enterobacter-Serratia group bacteria, in Algeria. Med. Mal. Infect. 42(1): 20-29. Crossref |
||||
|
Papanicolaou GA, Medeiros AA, Jacoby GA (1990). Novel plasmid-mediated betalactamase (MIR-1) conferring resistance to oxyimino-and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34: 2200–2209. Crossref |
||||
|
Philippon A, Arlet G, Jacoby GA (2002). Plasmid-determined AmpC-type b-lactamases. Antimicrob. Agents Chemother. 46: 1–11. Crossref |
||||
|
Podschun R, Ullmann U(1998). Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 11: 589-603. Pubmed |
||||
|
Rubin MA, Samore MH (2002). Antimicrobial Use and Resistance. Curr. Infect. Dis. Rep. 4: 491-497. Crossref |
||||
| Shah AA, Hasan F, Ahmed S, Hameed A (2004). Prevalence of extended spectrum B-lactamases in nosocomial and outpatients (ambulatory). Pak. J. Med. Sci. 19: 187–191. | ||||
|
Shu JC, Chia JH, Kuo AJ, Su LH, Wu TL (2010). A 7-year surveillance for ESBL-producing Escherichia coli and Klebsiella pneumoniae at a university hospital in Taiwan: the increase of CTX-M-15 in the ICU. Epidemiol. Infect. 138: 253-263. Crossref |
||||
|
Tobes R, Codo-er FM, López-Camacho E, Salanueva IJ, Manrique M, Brozynska M, et al. (2013). Genome Sequence of Klebsiella pneumoniae KpQ3, a DHA-1 β-Lactamase-Producing Nosocomial Isolate. Genome Announc. 1(1): e00167-12. Crossref |
||||
|
Valverde A, Coque TM, Garcìa-San Miguel L, Baquero F, Cantòn R (2008). Complex molecular epidemiology of extended-spectrum b-lactamases in Klebsiella pneumoniae: a long-term perspective from a single institution in Madrid. Antimicrob. Agents Chemother. 61: 64–72. Crossref |
||||
|
Villegas MV, Kattan JN, Quinteros MG, Casellas JM (2008). Prevalence of extended spectrum b-lactamases in South America. Clin. Microbiol. Infect. 14: 154–158. Crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
